Sfoglia per Autore
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry
2023 Buracchi, C; Belotti, D; Moretti, A; Calabretta, L; Risca, G; Capelli, C; Cabiati, B; Pedrini, O; Quaroni, M; Gotti, E; Matera, G; Cesana, S; Colombo, V; Rambaldi, B; Golay, J; Introna, M; Galimberti, S; Rambaldi, A; Biondi, A; Magnani, C; Gaipa, G
The Past, Present, and Future of Non-Viral CAR T Cells
2022 Moretti, A; Ponzo, M; Nicolette, C; Tcherepanova, I; Biondi, A; Magnani, C
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?
2020 Magnani, C; Tettamanti, S; Alberti, G; Pisani, I; Biondi, A; Serafini, M; Gaipa, G
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia
2018 Fazio, G; Turazzi, N; Cazzaniga, V; Kreuzaler, M; Maglia, O; Magnani, C; Biagi, E; Rolink, A; Biondi, A; Cazzaniga, G
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia
2018 Turazzi, N; Fazio, G; Rossi, V; Rolink, A; Cazzaniga, G; Biondi, A; Magnani, C; Biagi, E
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
2018 Magnani, C; Mezzanotte, C; Cappuzzello, C; Bardini, M; Tettamanti, S; Fazio, G; Cooper, L; Dastoli, G; Cazzaniga, G; Biondi, A; Biagi, E
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
2017 Arcangeli, S; Rotiroti, M; Bardelli, M; Simonelli, L; Magnani, C; Biondi, A; Biagi, E; Tettamanti, S; Varani, L
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia
2017 Biondi, A; Magnani, C; Tettamanti, S; Gaipa, G; Biagi, E
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform
2016 Magnani, C; Turazzi, N; Benedicenti, F; Calabria, A; Tenderini, E; Tettamanti, S; Giordano Attianese, G; Cooper, L; Aiuti, A; Montini, E; Biondi, A; Biagi, E
Donor-derived CD19-targeted T cells in allogeneic transplants
2015 Magnani, C; Biondi, A; Biagi, E
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo
2013 Bertilaccio, M; Tettamanti, S; Attianese, G; Galletti, G; Arcangeli, S; Rodriguez, T; Magnani, C; Barbaglio, F; Scarfò, L; Ponzoni, M; Biondi, A; Caligaris Cappio, F; Biagi, E; Ghia, P
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells
2013 Magnani, C; Turazzi, N; Benedicenti, F; Attianese, G; Tettamanti, S; Montini, E; Cooper, L; Aiuti, A; Biondi, A; Biagi, E
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors
2013 Tettamanti, S; Magnani, C; Biondi, A; Biagi, E
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives
2013 Magnani, C; Tettamanti, S; Maltese, F; Turazzi, N; Biondi, A; Biagi, E
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
2013 Gagliani, N; Magnani, C; Huber, S; Gianolini, M; Pala, M; Licona Limon, P; Guo, B; Herbert, D; Bulfone, A; Trentini, F; Di Serio, C; Bacchetta, R; Andreani, M; Brockmann, L; Gregori, S; Flavell, R; Roncarolo, M
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
2013 Tettamanti, S; Marin, V; Pizzitola, I; Magnani, C; GIORDANO ATTIANESE, G; Cribioli, E; Maltese, F; Galimberti, S; Lopez, A; Biondi, A; Bonnet, D; Biagi, E
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor
2012 Tettamanti, S; Marin, V; Pizzitola, I; Magnani, C; Attianese, G; Cribioli, E; Lopez, A; Biondi, A; Bonnet, D; Biagi, E
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells
2012 Andolfi, G; Fousteri, G; Rossetti, M; Magnani, C; Jofra, T; Locafaro, G; Bondanza, A; Gregori, S; Roncarolo, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile